IL17A and rheumatoid arthritis: Specifically, it decreases the production of several cytokines, including IL-17, IL-6, IL-10, and TNF-α, as well as IFN-γ in rheumatoid arthritis (RA) patients and induces Tregs in certain experimental models (Table 2) [111].